KRAS and neoplasm: We conclude that the overexpression of Col1a1 may suppress the transformed phenotype, whereas the downregulation of Col1a1 mediated by the codon 12 Kras mutation contributes to the neoplastic phenotype with the ability of tumour cells to metastasise.